Bleeding risk analysis in stroke imaging before thromboLysis (BRASIL): pooled analysis of T2*-weighted magnetic resonance imaging data from 570 patients. - Wikidata - thesis-toulmin - TriplyDB

Bleeding risk analysis in stroke imaging before thromboLysis (BRASIL): pooled analysis of T2*-weighted magnetic resonance imaging data from 570 patients.

Bleeding risk analysis in stroke imaging before thromboLysis (BRASIL): pooled analysis of T2*-weighted magnetic resonance imaging data from 570 patients.

http://www.wikidata.org/entity/Q31122516

about

Silent New Brain Lesions: Innocent Bystander or Guilty Party?Absolute and Relative Contraindications to IV rt-PA for Acute Ischemic Stroke.Postthrombolysis intracranial hemorrhage risk of cerebral microbleeds in acute stroke patients: a systematic review and meta-analysis Cerebral microbleeds: their associated factors, radiologic findings, and clinical implications Prognostic Impact of Cerebral Small Vessel Disease on Stroke Outcome Imaging recommendations for acute stroke and transient ischemic attack patients: A joint statement by the American Society of Neuroradiology, the American College of Radiology, and the Society of NeuroInterventional Surgery.Neuroimaging of cerebral ischemia and infarction Imaging of acute ischemic stroke.Microbubbles improve sonothrombolysis in vitro and decrease hemorrhage in vivo in a rabbit stroke model.Advanced neuroimaging to guide acute stroke therapy.Cerebral microbleeds and the risk of intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: systematic review and meta-analysis Use of perfusion imaging and other imaging techniques to assess risks/benefits of acute stroke interventions.Collateral Circulation in Ischemic Stroke: Assessment Tools and Therapeutic Strategies Cerebral microbleeds: a guide to detection and interpretation.Use of magnetic resonance imaging to predict outcome after stroke: a review of experimental and clinical evidence.Cerebral microbleeds (CMBs) - relevance for mechanisms of cerebral hemorrhage--analysis of 24 MRI evaluated patients.Imaging and treatment of patients with acute stroke: an evidence-based review.Importance of leukoaraiosis on CT for tissue plasminogen activator decision making: evaluation of the NINDS rt-PA Stroke Study.Current acute stroke trials and their potential impact on the therapeutic time window.Current concepts on magnetic resonance imaging (MRI) perfusion-diffusion assessment in acute ischaemic stroke: a review & an update for the clinicians Hemorrhagic Transformation after Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke: Mechanisms, Models, and Biomarkers.Prevention and Management of Cerebral Small Vessel Disease Increased Risk of Post-Thrombolysis Intracranial Hemorrhage in Acute Ischemic Stroke Patients with Leukoaraiosis: A Meta-Analysis.Cerebral microbleeds and postthrombolysis intracerebral hemorrhage risk Updated meta-analysis.A cohort study of relationship between serum calcium levels and cerebral microbleeds (CMBs) in ischemic stroke patients with AF and/or RHD.Cerebral microbleeds: a new dilemma in stroke medicine Safety and efficacy of alteplase in the treatment of acute ischemic stroke Risk of symptomatic intracerebral hemorrhage in patients treated with intra-arterial thrombolysis.Microbleeds versus macrobleeds: evidence for distinct entities Theoretic basis and technical implementations of CT perfusion in acute ischemic stroke, part 1: Theoretic basis.Cerebral microbleeds: a review of clinical, genetic, and neuroimaging associations.Use of neuroimaging in acute stroke trials.Clinical Outcome in Acute Ischemic Stroke Patients With Microbleeds After Thrombolytic Therapy: A Meta-Analysis.The Presence of Previous Cerebral Microbleeds Has a Negative Effect on Hypertensive Intracerebral Hemorrhage Recovery.Clinical predictors and management of hemorrhagic transformation.Commonly asked questions: thrombolytic therapy in the management of acute stroke.Use of intravenous recombinant tissue plasminogen activator in patients outside the defined criteria: safety and feasibility issues.Cerebral microbleeds: a guide to detection and clinical relevance in different disease settings.Intravenous thrombolysis in acute ischemic stroke: standard and potential future applications.Safety of intravenous thrombolysis for acute ischemic stroke in specific conditions.

P2860

Q26783036-3C6DCCA8-F84B-42F1-8BBF-BB4229EF57A4 Q26796474-8904377B-724B-4B64-B829-3513A7B1C66B Q27001565-03E21CE6-60BA-4A95-BCC9-A047BDE47B34 Q27021866-A16C0CAC-94EC-484B-925B-228B3C68175A Q28082475-AA0D65A3-CB01-45D6-8E13-F9DEE0B56879 Q30409698-104854FD-6C27-4581-B667-30BE69FF748B Q30428970-AB4D07D6-6EFA-4CB0-AD26-70BB50011AE2 Q30430085-65286C57-B201-4772-B019-BEA85048368D Q30446434-C2663388-696E-4C39-A2B1-7A5694AB5B08 Q30570153-456B7CEB-BABC-4DF5-9DDE-3E6B0CC0066C Q30571437-A06AEED0-21C5-4B0E-80AF-A05069EE0515 Q30625019-E5FBBF7F-1AC9-41E5-A6B3-D82F8AA326C8 Q31003648-9756B273-E108-4C34-ACD8-E572FEE44436 Q33401999-22D17313-6B20-4283-935B-F0BC365AA394 Q33525255-492D2D6D-C44C-4EB6-8E9B-33BE4C7C0DB7 Q33665991-DF360EE1-2D9C-4F02-8ABF-50A25EE39DC2 Q33926874-ACE5E5C2-3529-4C21-BCBB-1AA547A4EB9E Q34038319-9FC4021A-7794-4F73-B86C-F93290942A38 Q34144576-33435EA4-90EA-4101-B60C-3BE16AEDEAFD Q35193594-86CF5376-34A3-4111-8BB0-BAC82C053770 Q35567319-B96A7373-B857-4E75-9156-F795859070EF Q35698425-62ACC98A-BC7A-4A96-913A-234509209180 Q35994574-886EFF2A-E5D6-4C42-AEEB-F0A9046AE6A0 Q36052933-B17E6759-CF51-4970-8189-A6868E2E91D2 Q37078015-232EA845-EB53-4D03-9D9B-3AC9C0283260 Q37082606-79F1CF98-E9BB-4D31-B5C5-77CEB6D3C9CA Q37202149-6DA42D9F-AA7C-41BA-AB75-8C5D02533740 Q37274254-76598ED2-2E51-4767-8B75-477DF9A2994F Q37378502-74E6EAF6-9DD4-4BFC-B26A-9F91C9395DCF Q37409006-8D4E0504-9373-4E20-8168-04656DC118F7 Q37435248-13C8FB12-A46A-46DB-AE80-A94FD7548D7F Q37507984-FF415BBF-CAA5-485C-97F0-C84D6ADB4057 Q37624233-709D19FA-7478-4E90-B152-CF9B8AC6719D Q37683256-8B23B40E-E30B-4666-BE1E-E688D9BBA780 Q38074569-976C5E49-92E9-4AAA-9602-C379D6711BEF Q38078026-3D574015-A6B5-430C-9073-6169A8632E88 Q38078028-D0493095-6C4F-4E99-A867-B9495F8ABEB5 Q38109534-33B40F1A-9AC7-483D-9B3B-D15ACC3D1045 Q38225341-F67AD0C1-E3CA-4F98-B5CD-4B8F80869679 Q38407477-892AE52D-A27A-45FE-BF40-D72156481409

P2860

Bleeding risk analysis in stroke imaging before thromboLysis (BRASIL): pooled analysis of T2*-weighted magnetic resonance imaging data from 570 patients.

http://www.wikidata.org/entity/Q31122516

description

2007 nî lūn-bûn

@nan

2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Bleeding risk analysis in stro ...... maging data from 570 patients.

@ast

Bleeding risk analysis in stro ...... maging data from 570 patients.

@en

type

label

Bleeding risk analysis in stro ...... maging data from 570 patients.

@ast

Bleeding risk analysis in stro ...... maging data from 570 patients.

@en

prefLabel

Bleeding risk analysis in stro ...... maging data from 570 patients.

@ast

Bleeding risk analysis in stro ...... maging data from 570 patients.

@en

P1433

Q31122516-DBD85DEB-A22B-40C2-A9EE-04E2EC16CD46

P1476

Q31122516-AF8642B2-CF6C-4A32-956F-38848C83AA83

P2093

Q31122516-065EF345-2B74-4778-B25C-96F80B87726A

Q31122516-164649F4-2DFE-44F4-AB93-36D98769AEE8

Q31122516-194AA081-2D83-41C3-A9D3-41CAC37D07F5

Q31122516-2AA89DE0-5A68-48CD-8239-DE9C247334CD

Q31122516-5013FD6D-97F0-4736-AC99-467767DE4ED5

Q31122516-63FDE952-FD48-400F-8F27-9E4A02678ECE

Q31122516-6483BD7C-3EDF-45DB-818E-4BA39505050C

Q31122516-6A94C913-7F2E-4917-9FAC-A1F26B79BBF6

Q31122516-75153839-50F7-4A0F-B1AB-56C72FFB416B

Q31122516-755C9ABC-52CF-4B53-8058-8988996FBBCF

P304

Q31122516-317A3D16-4ACF-45DB-8206-5567AF7CAC06

P31

Q31122516-EE51E8D3-62DF-4D7D-88AB-6CEA36E9A24A

P356

Q31122516-EE6A9425-E013-4B78-A17E-CB6E14B7488E

P407

Q31122516-4A6DCF94-AF4A-475E-8B1D-25CA9AD249F5

P433

Q31122516-FDB59097-5644-467F-8A91-6858422C4E3A

P478

Q31122516-391D8113-39E9-413E-8DB1-CBF86E523AF2

P50

Q31122516-6260FCF6-E636-4939-A6C2-9F635DD44EAD

P577

Q31122516-40010A66-D1DD-4E8A-A1DB-BE89A026D425

P698

Q31122516-4DC9AD96-2A7C-4711-B27A-1A8E2EA74974

P921

Q31122516-A40381F2-4020-432D-B64D-7B224BE9B7B8

P356

STROKEAHA.106.480848

P1433

P1476

Bleeding risk analysis in stro ...... maging data from 570 patients.

@en

P2093

Achim Gass

http://www.w3.org/2001/XMLSchema#string

Alex Rovira

http://www.w3.org/2001/XMLSchema#string

David S Liebeskind

http://www.w3.org/2001/XMLSchema#string

Gregory W Albers

http://www.w3.org/2001/XMLSchema#string

Jean-Martin Boulanger

http://www.w3.org/2001/XMLSchema#string

Jens Fiehler

http://www.w3.org/2001/XMLSchema#string

Joachim Rother

http://www.w3.org/2001/XMLSchema#string

Johannes Trenkler

http://www.w3.org/2001/XMLSchema#string

Jong S Kim

http://www.w3.org/2001/XMLSchema#string

Laurent Derex

http://www.w3.org/2001/XMLSchema#string

P304

2738-2744

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/STROKEAHA.106.480848

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P50

Peter M. Rothwell

P577

2007-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17717319

http://www.w3.org/2001/XMLSchema#string

P921